Exact Mass: 390.0263

Exact Mass Matches: 390.0263

Found 202 metabolites which its exact mass value is equals to given mass value 390.0263, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

O-Carbamoyladenylate

5-O-[(S)-(Carbamoyloxy)(Hydroxy)phosphoryl]adenosine

C11H15N6O8P (390.0689)

8-Nitro-cGMP

2-amino-9-{2,7-dihydroxy-2-oxo-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl}-8-nitro-6,9-dihydro-1H-purin-6-one

C10H11N6O9P (390.0325)

3,4,9,10-Perylenetetracarboxylic Diimide

8,17-dihydroxy-7,18-diazaheptacyclo[14.6.2.2²,⁵.0³,¹².0⁴,⁹.0¹³,²³.0²⁰,²⁴]hexacosa-1(22),2(26),3(12),4(9),5(25),7,10,13(23),14,16(24),17,20-dodecaene-6,19-dione

C24H10N2O4 (390.0641)

Clofibryl glucuronide

6-{[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H19ClO9 (390.0718)

(3E,6S,7S,9S,10S,12S,13R)-10,12-dibromo-6,9:7,13-bisepoxypentadec-3-en-1-yne|10,12-Dibromo-6,9:7,13-diepoxy-3-pentadecen-1-yne

C15H20Br2O2 (389.983)

5-methoxy-3,4,3-tri-O-methylflavellagic acid

C18H14O10 (390.0587)

Euclanon

C22H14O7 (390.0739)

3-hydroxydiospyrin

C22H14O7 (390.0739)

Bunodosin 391

C16H15BrN4O3 (390.0327)

Kniphofione A

C22H14O7 (390.0739)

C22H14O7

C22H14O7 (390.0739)

1,6,8-Trihydroxy-3-methyl-4-(benzoyloxy)-9,10-anthraquinone

C22H14O7 (390.0739)

Euclanone

C22H14O7 (390.0739)

Barbatolic acid

C18H14O10 (390.0587)

2,2-Oxybis(3-methyl-8-hydroxy-1,4-naphthoquinone)

C22H14O7 (390.0739)

Pinnatifate

C17H24BrClO3 (390.0597)

8-Acetyl-6,11-dihydroxy-1-methoxynaphthacenequinon

C22H14O7 (390.0739)

Statil

PONALRESTAT

C17H12BrFN2O3 (390.0015)

C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D007004 - Hypoglycemic Agents D004791 - Enzyme Inhibitors

Sulfadoxine suflate

C12H14N4O7S2 (390.0304)

phosphatidylinositol

1,2-Diacyl-sn-glycero-3-phosphoinositol

C11H19O13P (390.0563)

4-iodo-SAHA

N1-hydroxy-N8-(4-iodophenyl) octanediamide

C14H19IN2O3 (390.044)

Thuwalallene C

C15H20O2Br2 (389.983)

Thuwalallene E

C15H20O2Br2 (389.983)

thuwalenyne A

C15H20O2Br2 (389.983)

thuwalenyne B

C15H20O2Br2 (389.983)

thiencarbazone-methyl

C12H14N4O7S2 (390.0304)

3,5-di-o-acetyl-5-bromo-2-deoxy-d-uridine

C13H15BrN2O7 (390.0063)

4-(5-carboxy-7-methoxy-1,3-benzodioxol-4-yl)-7-methoxy-1,3-benzodioxole-5-carboxylic acid

C18H14O10 (390.0587)

Triclopyricarb

C15H13Cl3N2O4 (389.9941)

3-BENZYL-2-(1-BROMO-PROPYL)-7-CHLORO-3H-QUINAZOLIN-4-ONE

C18H16BrClN2O (390.0134)

1,2-BIS[3-(TRIFLUOROMETHYL)PHENYL]-1,1,2,2-TETRAFLUOROETHANE 97

C16H8F10 (390.0466)

2-[(4-chloro-2-nitrophenyl)azo]-N-(2-methoxyphenyl)-3-oxobutyramide

C17H15ClN4O5 (390.0731)

vanox zmti

C16H14N4S2Zn (389.9951)

Fluorescein-O-acetic acid

C22H14O7 (390.0739)

6-BROMO-4-(2-(PYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL-3-YL)QUINOLINE

C20H15BrN4 (390.048)

aluminium tribenzoate

C21H15AlO6 (390.0684)

ethyl 1-bromo-4-(2-bromoethyl)-4a,5,6,7,8,8a-hexahydronaphthalene-2-carboxylate

C15H20Br2O2 (389.983)

Letrazuril

C17H9Cl2FN4O2 (390.0087)

C254 - Anti-Infective Agent

(2R,4S)-4-nitrobenzyl 4-Mercapto-2-((sulfaMoylaMino)Methyl)pyrrolidine-1-carboxylate

C13H18N4O6S2 (390.0668)

1-(6-chloropyrimidin-4-yl)-3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylurea

C14H13Cl3N4O3 (390.0053)

Calcium ascorbate

Calcium diascorbate

C12H14CaO12 (390.0111)

D020011 - Protective Agents > D000975 - Antioxidants D018977 - Micronutrients > D014815 - Vitamins

4-Heptanone,1,1,1,7,7,7-hexafluoro-2,6-dihydroxy-2,6-bis(trifluoromethyl)-

C9H6F12O3 (390.0125)

4-Bromobenzo-18-crown-6

C16H23BrO6 (390.0678)

Unii-B55T45AA8F

C16H15Cl2F3N4 (390.0626)

4H-Pyrazino(1,2-a)pyrimidin-4-one, 2-(2-dimethylaminoethoxy)-3-phenyl-, hydrobromide

C17H19BrN4O2 (390.0691)

Bunodosine 391

C16H15BrN4O3 (390.0327)

A N-acylamino acid that is L-histidine acylated at the nitrogen atom of the amino group by a (6-bromo-1H-indol-3-yl)acetyl residue. Isolated from the venom of the sea anemone Bunodosoma cangicum, it exhibits analgesic activity. D009676 - Noxae > D011042 - Poisons > D003064 - Cnidarian Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

2-(3-benzoylthioureido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid

C18H18N2O4S2 (390.0708)

CID-1067700 (ML282) is a pan GTPase inhibitor, and competitively inhibits Ras-related in brain 7 (Rab7) with a Ki of 13 nM.

8-Nitro-cGMP

C10H11N6O9P (390.0325)

1-[(4-Chlorophenyl)methyl]-3-(3-fluorophenyl)-1-(3,3,3-trifluoro-2-hydroxypropyl)urea

C17H15ClF4N2O2 (390.0758)

3,4-Dihydro-4-hydroxy-2-(4-methoxyphenyl)-2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide

C13H14N2O6S3 (390.0014)

2,3-Dideoxy-3-fluoro-urididine-5-diphosphate

C9H13FN2O10P2 (390.0029)

4-Hydroxybutylglucosinolate

C11H20NO10S2- (390.0529)

2-amino-9-(2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)-8-nitro-1H-purin-6-one

C10H11N6O9P (390.0325)

1-[5-(Trifluoromethyl)-1,3,4-thiadiazol-2-yl]-3-[1,1,1-trifluoro-2-(trifluoromethyl)butan-2-yl]urea

C9H7F9N4OS (390.0197)

4-(4-bromophenyl)-2-[4-(2H-tetrazol-5-yl)-1-piperidinyl]thiazole

C15H15BrN6S (390.0262)

1-[(5-Bromo-2-thienyl)carbonyl]-4-(3-phenyl-2-propen-1-yl)piperazine

C18H19BrN2OS (390.0401)

methyl 2-[5-[(E)-(5-aminotetrazol-1-yl)iminomethyl]furan-2-yl]-5-bromobenzoate

C14H11BrN6O3 (390.0076)

N-benzoyl-5-(3,5-dichlorophenoxy)-2-furancarbohydrazide

C18H12Cl2N2O4 (390.0174)

1-(4-Bromophenyl)-3-[4-(2-fluorophenyl)-1-piperazinyl]-1-propanone

C19H20BrFN2O (390.0743)

2-Hydroxy-2-methylpropylglucosinolate

C11H20NO10S2- (390.0529)

methyl (2Z)-5-(4-chlorobenzoyl)-2-(dimethylaminomethylidene)-3-oxopyrrolo[2,1-b][1,3]thiazole-7-carboxylate

C18H15ClN2O4S (390.0441)

3-[[(4S)-2-(dichloromethyl)-4-hydroxy-5-oxooxolan-2-yl]methyl]-8-hydroxy-6-methoxy-4a,8a-dihydroisochromen-1-one

C16H16Cl2O7 (390.0273)

(2S,3S,4S,5R)-6-[(3R)-3-(4-chlorophenyl)-4-hydroxybutanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C16H19ClO9 (390.0718)

2:2 Fluorotelomer phosphate diester

C8H9F10O4P (390.0079)

1,4-Bis(trimethylstannyl)-2-butenylene

C10H30Sn2 (390.0391)

5-O-[(S)-(Carbamoyloxy)(Hydroxy)phosphoryl]adenosine

C11H15N6O8P (390.0689)

Pigment Violet 29

3,4,9,10-Perylenetetracarboxylic Diimide

C24H10N2O4 (390.0641)

glucoconringiin(1-)

C11H20NO10S2 (390.0529)

An hydroxy-alkylglucosinolate that is isobutylglucosinolate which has been hydroxylated at the 2-position of the isobutyl chain.

8-nitroguanosine 3,5-cyclic monophosphate

C10H11N6O9P (390.0325)

A 3,5-cyclic purine nucleotide that is guanosine 3,5-cyclic monophosphate in which the hydrogen at position 8 on the purine fragment has been replaced by a nitro group.

A3373

C17H9F7N2O (390.0603)

A3373, a novel chemical inhibitor of Phospholipase D1 (PLD1) and PLD2, with IC50 of 325 nM and 15.15?μM, respectively, inhibits LPS-induced immune response and plays important roles in autoimmune arthritis, bone demineralization and osteoclastogenesis[1][2].

GSK1940029

C18H16Cl2N4O2 (390.065)

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD) inhibitor extracted from patent WO/2009060053 A1, compound example 16.

(2r,3as,5r,9as)-2-(3-bromopropa-1,2-dien-1-yl)-5-[(1s)-1-bromopropyl]-2h,3h,3ah,5h,6h,9h,9ah-furo[3,2-b]oxocine

C15H20Br2O2 (389.983)

(2s,3s,4ar,6s,7s,8ar)-3,7-dibromo-2-ethyl-6-[(2z)-pent-2-en-4-yn-1-yl]-octahydropyrano[3,2-b]pyran

C15H20Br2O2 (389.983)

(2s,3as,5r,9as)-2-(3-bromopropa-1,2-dien-1-yl)-5-(1-bromopropyl)-2h,3h,3ah,5h,6h,9h,9ah-furo[3,2-b]oxocine

C15H20Br2O2 (389.983)

(2r,3as,5s,6s,10as)-6-bromo-2-(3-bromopropa-1,2-dien-1-yl)-5-ethyl-2h,3h,3ah,5h,6h,7h,10h,10ah-furo[3,2-b]oxonine

C15H20Br2O2 (389.983)

3,8-dibromo-4,11,12,12-tetramethyl-7-oxatricyclo[6.3.1.0¹,⁶]dodeca-3,9-dien-11-ol

C15H20Br2O2 (389.983)

(4s,4's,5r,5'r)-4,4'-dibromo-5-ethyl-5'-[(2z)-pent-2-en-4-yn-1-yl]-2,2'-bioxolane

C15H20Br2O2 (389.983)

9-hydroxy-4-[(7-methoxy-2-oxochromen-8-yl)methyl]furo[3,2-g]chromen-7-one

9-hydroxy-4-[(2-keto-7-methoxy-chromen-8-yl)methyl]furo[3,2-g]chromen-7-one; 9-hydroxy-4-[(7-methoxy-2-oxo-8-chromenyl)methyl]-7-furo[3,2-g]chromenone; 9-hydroxy-4-[(7-methoxy-2-oxo-chromen-8-yl)methyl]furo[3,2-g]chromen-7-one

C22H14O7 (390.0739)

{"Ingredient_id": "HBIN014115","Ingredient_name": "9-hydroxy-4-[(7-methoxy-2-oxochromen-8-yl)methyl]furo[3,2-g]chromen-7-one","Alias": "9-hydroxy-4-[(2-keto-7-methoxy-chromen-8-yl)methyl]furo[3,2-g]chromen-7-one; 9-hydroxy-4-[(7-methoxy-2-oxo-8-chromenyl)methyl]-7-furo[3,2-g]chromenone; 9-hydroxy-4-[(7-methoxy-2-oxo-chromen-8-yl)methyl]furo[3,2-g]chromen-7-one","Ingredient_formula": "C22H14O7","Ingredient_Smile": "NA","Ingredient_weight": "390.34","OB_score": "20.29130599","CAS_id": "265096-90-0","SymMap_id": "SMIT05644","TCMID_id": "NA","TCMSP_id": "MOL003598","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5,7,17,19-tetrahydroxy-11-(hydroxymethyl)-2-oxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(22),3(12),4(9),5,7,10,13,16,18,20-decaen-15-one

C22H14O7 (390.0739)

5,13,17-trihydroxy-4,12-bis(hydroxymethyl)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,11,13-hexaene-9,15-dione

C18H14O10 (390.0587)

19,20-dichloro-16-oxapentacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²²]tetracosa-1(14),2(11),3,5,7,9,12,15(22),17,19,23-undecaen-21-one

C23H12Cl2O2 (390.0214)

(1r,7s,8s,11r)-7-hydroxy-11-(hydroxymethyl)-17-methyl-12,13,14,15-tetrathia-9,17-diazatetracyclo[9.4.2.0¹,⁹.0³,⁸]heptadeca-3,5-diene-10,16-dione

C13H14N2O4S4 (389.9836)

6,12-dihydroxy-5,7,13,14-tetramethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C18H14O10 (390.0587)

7-hydroxy-11-(hydroxymethyl)-17-methyl-12,13,14,15-tetrathia-9,17-diazatetracyclo[9.4.2.0¹,⁹.0³,⁸]heptadeca-3,5-diene-10,16-dione

C13H14N2O4S4 (389.9836)